24/7 Patient Assistance: 760-405-8205

James Tsai, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. James Tsai is a medical oncology specialist in Hemet, California and he works at several hospitals in the area, including Inland Valley Medical Center and Hemet Valley Medical Center. He got his diploma from St. George's University School of Medicine and did his residency in Internal Medicine/Pediatrics at UMDNJ-University Hospital. Dr. James Tsai also completed a fellowship in Hematology/Oncology at Brown University. The doctor is certified in Hematology, Internal Medicine, Medical Oncology and Pediatrics and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    St. George's University

    Medical School

    dept_icon

    UMDNJ-University Hospital

    Residency

    dept_icon

    Brown University

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Loma Linda University Medical Center

    Languages: English/Spanish

    (909) 558-4000

    11234 Anderson St

    Loma Linda, California 92354

    Read More

    Southwest Healthcare System

    Languages: English/Spanish

    (951) 677-1111

    36485 Inland Valley Dr

    Wildomar, California 92595

    Read More
  • Publications & Memberships

    Dr. James Tsai has contributed to 3 publications.

    Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma.

    Hsueh CT, Selim JH, Tsai JY, Hsueh CT; World J Gastroenterol. 2016 Aug 21.

    See more >>

    Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells.

    Kuo, C. C.,Chen, J. J.,Tsai, J. Y.,Hsueh, C. T.; Biomark Res. 2015 Jan 02.

    See more >>

    Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.

    Tsai, J.Y., Iannitti, D., Berkenblit, A., Akerman, P., Nadeem, A., Rathore, R., Harrington, D., Roye, D., Miner, T., Barnett, J.M., Maia, C., Stuart, K., Safran, H.; Am J Clin Oncol. 2005 Aug.

    See more >>